Details of the Drug-Related molecule(s) Expression Atlas
General Information of Drug (ID: DMX8NYD)
Drug Name | ||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2,3,4,5-Tetrahydro-1H-pyrido[4,3-b]indole; 6208-60-2; 2,3,4,5-Tetrahydro-1h-pyrido[4,3,b]indole; 1H,2H,3H,4H,5H-pyrido[4,3-b]indole; 1H-Pyrido[4,3-b]indole, 2,3,4,5-tetrahydro-; MLS001198355; 1,2,3,4-tetrahydropyridino[4,3-b]indole; SMR000559186; SR-01000530765; PubChem2433; BAS 00107381; AC1Q1GJA; AC1LF5C1; Oprea1_367545; SCHEMBL169954; CHEMBL269074; AC1Q1H88; CTK5B4311; BDBM73071; DTXSID50352329; cid_11572011; MolPort-000-928-989; RPROHCOBMVQVIV-UHFFFAOYSA-N; ALBB-007677; KS-00000E6L; STK500458; BBL010407; ANW-57714; ZINC19228212
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecule(s) Related to This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs
|
|||||||||||||||||||||||||||||||||
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue
The Studied Disease | Discovery agent | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue | ||||||||||||||||||||||||||||||